Medirom Healthcare Company Leadership
| MRM Stock | USD 6.08 0.08 1.33% |
Medirom Healthcare employs about 434 people. The company is managed by 33 executives with a total tenure of roughly 414 years, averaging almost 12.0 years of service per executive, having 13.15 employees per reported executive. Analysis of Medirom Healthcare's management performance can provide insight into the firm performance.
| Jeffrey Weber CEO CEO, Managing Director, Executive Director |
| Joseph Fuda CEO President CEO, Director |
Medirom |
Medirom Healthcare Management Team Effectiveness
At this time, Medirom Healthcare's Return On Tangible Assets are very stable compared to the past year. As of the 19th of April 2024, Return On Capital Employed is likely to grow to 0.07, though Return On Equity is likely to grow to (2.14). At this time, Medirom Healthcare's Intangible Assets are very stable compared to the past year. As of the 19th of April 2024, Return On Tangible Assets is likely to grow to 0.03, though Net Tangible Assets are likely to grow to (1 B). Medirom Healthcare's management efficiency ratios could be used to measure how well Medirom Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.As of the 19th of April 2024, Common Stock Shares Outstanding is likely to drop to about 5.2 M. In addition to that, Net Loss is likely to grow to about (847.1 M)
Medirom Healthcare Workforce Comparison
Medirom Healthcare Technologies is rated below average in number of employees category among related companies. The total workforce of Consumer Discretionary industry is now estimated at about 47,176. Medirom Healthcare maintains roughly 434 in number of employees contributing less than 1% to stocks in Consumer Discretionary industry.
Medirom Healthcare Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Medirom Healthcare Price Series Summation is a cross summation of Medirom Healthcare price series and its benchmark/peer.
Medirom Healthcare Notable Stakeholders
A Medirom Healthcare stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medirom Healthcare often face trade-offs trying to please all of them. Medirom Healthcare's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medirom Healthcare's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jeffrey Weber | CEO, Managing Director, Executive Director | Profile | |
| Joseph Fuda | President CEO, Director | Profile | |
| Jacques Blanchard | Chairman of the Board, CEO | Profile | |
| Anthony Howarth | Independent Non-Executive Chairman of the Board | Profile | |
| Salvatore Fuda | Chairman of the Board | Profile | |
| Steven Fleet | President of MAST, Inc.; Director | Profile | |
| Dan Amadori | CFO | Profile | |
| Peter Raynor | CFO | Profile | |
| David Ross | COO | Profile | |
| Eva Howell | Non-Executive Director | Profile | |
| Alex Dey | Independent Director | Profile | |
| Brigitte GauthierDarcet | Independent Director | Profile | |
| Chiang Heng | Non-Executive Director | Profile | |
| Mark Bradley | Non-Executive Independent Director | Profile | |
| Brian Herzen | Independent Director | Profile | |
| Craig Carlson | Independent Director | Profile | |
| Francois Varenne | Director - Representative of SCOR SE | Profile | |
| Jean Guitton | Director | Profile | |
| Gerard Aubert | Independent Director | Profile | |
| Oliver Nepomuceno | Independent Director | Profile | |
| Karina Lelievre | Director - Representative of SCOR SE | Profile | |
| Hugh Edwards | Non-Executive Director | Profile | |
| Larry Blue | Independent Director | Profile | |
| David Sharpless | Independent Director | Profile | |
| Dylan DarbyshireRoberts | Company Secretary | Profile | |
| Darren Thomas | General Manager - Health, Safety, Environment & Quality | Profile | |
| Michael Gillett | General Manager - Human Resources | Profile | |
| Kouji Eguchi | CEO Director | Profile | |
| David Lofthouse | General Manager - Business Development | Profile | |
| Liz Buckey | General Manager - Corporate Development | Profile | |
| Fumitoshi Fujiwara | CFO Director | Profile | |
| Daylan Roberts | General Manager Legal, Company Secretary | Profile | |
| Akira Aoki | Executive Officer | Profile |
About Medirom Healthcare Management Performance
The success or failure of an entity such as Medirom Healthcare often depends on how effective the management is. Medirom Healthcare management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medirom management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medirom management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.03 | 0.03 | |
| Return On Capital Employed | 0.06 | 0.07 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | (2.26) | (2.14) |
The data published in Medirom Healthcare's official financial statements usually reflect Medirom Healthcare's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Medirom Healthcare. For example, before you start analyzing numbers published by Medirom accountants, it's critical to develop an understanding of what Medirom Healthcare's liquidity, profitability, and earnings quality are in the context of the Hotels, Restaurants & Leisure space in which it operates.
Please note, the presentation of Medirom Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medirom Healthcare's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Medirom Healthcare's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medirom Healthcare Technologies. Please utilize our Beneish M Score to check the likelihood of Medirom Healthcare's management manipulating its earnings.
Medirom Healthcare Workforce Analysis
Traditionally, organizations such as Medirom Healthcare use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medirom Healthcare within its industry.Medirom Healthcare Manpower Efficiency
Return on Medirom Healthcare Manpower
| Revenue Per Employee | 12.5M | |
| Revenue Per Executive | 163.9M | |
| Net Loss Per Employee | 2.3M | |
| Net Loss Per Executive | 30M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Medirom Stock analysis
When running Medirom Healthcare's price analysis, check to measure Medirom Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medirom Healthcare is operating at the current time. Most of Medirom Healthcare's value examination focuses on studying past and present price action to predict the probability of Medirom Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medirom Healthcare's price. Additionally, you may evaluate how the addition of Medirom Healthcare to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Medirom Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.05) | Revenue Per Share 1.4 K | Quarterly Revenue Growth 0.03 | Return On Assets (0.01) | Return On Equity (7.00) |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.